:

ANDURIL HITS $61B VALUATION IN $5B FUNDING ROUND

INDUSTRY DESK1 MIN READ
WED, MAY 13, 2026

■ AI-SUMMARIZED FROM 3 SOURCES ▸ TIMELINE

Defense technology company Anduril Industries has secured $5 billion in funding, bringing its valuation to $61 billion. The round was led by Thrive Capital and Andreessen Horowitz.

Anduril Industries announced the funding round on Wednesday, marking a significant milestone for the defense-focused startup. The $5 billion investment places the company among the most valuable private firms in the sector. Thrive Capital and Andreessen Horowitz co-led the financing, signaling strong institutional confidence in Anduril's business model and growth trajectory. The round adds to previous funding that has supported the company's expansion. About Anduril Anduril develops autonomous systems and software for defense applications. The company focuses on providing technology solutions for military and government customers, competing in a space where defense innovation has become increasingly important. Market Context The funding reflects ongoing investor appetite for defense technology startups, particularly those developing autonomous systems and artificial intelligence capabilities. Defense spending has remained robust, and private companies in the sector have attracted substantial capital. Anduril's $61 billion valuation places it among a select group of defense-focused startups that have achieved unicorn status and beyond. The company has expanded its team and capabilities significantly since its founding. Next Steps With the fresh capital, Anduril is positioned to accelerate product development and expand its customer base. The company continues to recruit talent in engineering and defense technology specialization. The funding comes as defense technology remains a priority for government spending and as geopolitical tensions continue to drive investment in advanced military capabilities.

■ SOURCES

Bloomberg TechTechCrunchBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

16H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

16H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

23H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.